| scholarly article | Q13442814 |
| P50 | author | Sallie R Permar | Q87955622 |
| Hua-Xin Liao | Q88608388 | ||
| R Glenn Overman | Q114780420 | ||
| P2093 | author name string | M Anthony Moody | |
| Joshua D Amos | |||
| Thaddeus C Gurley | |||
| Lisa Colvin | |||
| Krista Beck | |||
| David R Martinez | |||
| Jonathon E Himes | |||
| Lawrence Armand | |||
| P2860 | cites work | Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals | Q24635002 |
| Structural definition of a conserved neutralization epitope on HIV-1 gp120 | Q24655948 | ||
| Natural SIV Hosts: Showing AIDS the Door | Q27026135 | ||
| Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 | Q27644478 | ||
| Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus | Q27644501 | ||
| Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 | Q27663293 | ||
| Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding | Q27670829 | ||
| Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing | Q27671696 | ||
| A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield | Q27675032 | ||
| Broad and potent neutralization of HIV-1 by a gp41-specific human antibody | Q27675131 | ||
| Island biogeography reveals the deep history of SIV | Q28293475 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target | Q29547347 | ||
| Broad neutralization coverage of HIV by multiple highly potent antibodies | Q29615361 | ||
| Rapid evolution of the neutralizing antibody response to HIV type 1 infection | Q29618603 | ||
| Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
| Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 | Q29619511 | ||
| Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm). | Q30766349 | ||
| Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. | Q31016954 | ||
| Going wild: lessons from naturally occurring T-lymphotropic lentiviruses | Q31066870 | ||
| Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys | Q33518502 | ||
| Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals | Q33526340 | ||
| Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys | Q33597744 | ||
| Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection | Q33702217 | ||
| Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease | Q33782693 | ||
| Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. | Q33806000 | ||
| Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies | Q33877434 | ||
| Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies | Q34006748 | ||
| Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting | Q34042758 | ||
| Apparent lack of vertical transmission of simian immunodeficiency virus (SIV) in naturally infected African green monkeys, Cercopithecus aethiops. | Q45790312 | ||
| Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus | Q45848000 | ||
| Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys | Q45850937 | ||
| Development of the antibody response in acute HIV-1 infection | Q47747470 | ||
| Progress in HIV-1 vaccine development | Q56600657 | ||
| Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys | Q34046182 | ||
| Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice | Q34180174 | ||
| Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys | Q34290999 | ||
| Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein | Q34301897 | ||
| A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 | Q34306804 | ||
| Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts | Q34647780 | ||
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia | Q34848486 | ||
| In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth | Q34937404 | ||
| HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria | Q34957769 | ||
| Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women | Q35058698 | ||
| Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved | Q35073270 | ||
| The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection | Q35076717 | ||
| Mother-to-Infant Transmission of Simian Immunodeficiency Virus Is Rare in Sooty Mangabeys and Is Associated with Low Viremia | Q35077005 | ||
| Target cell availability, rather than breast milk factors, dictates mother-to-infant transmission of SIV in sooty mangabeys and rhesus macaques | Q35113475 | ||
| HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies | Q35192641 | ||
| High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys. | Q35192646 | ||
| Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors | Q35382871 | ||
| Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated | Q35441583 | ||
| A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses | Q35569049 | ||
| Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors | Q35857221 | ||
| Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection | Q35857268 | ||
| Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates | Q35914306 | ||
| Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection | Q36423897 | ||
| Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding | Q36673279 | ||
| Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses | Q36693991 | ||
| Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation | Q36827309 | ||
| HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. | Q36874604 | ||
| Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys | Q36996108 | ||
| Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm | Q37247974 | ||
| Lack of B Cell Dysfunction Is Associated with Functional, gp120-Dominant Antibody Responses in Breast Milk of Simian Immunodeficiency Virus-Infected African Green Monkeys | Q37252604 | ||
| Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host | Q37365356 | ||
| Measuring HIV neutralization in a luciferase reporter gene assay | Q39914262 | ||
| HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages | Q42270590 | ||
| Mother‐to‐infant transmission of SIV via breast‐feeding in rhesus macaques | Q45198562 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Simian immunodeficiency virus | Q1890246 |
| P304 | page(s) | 9485-9498 | |
| P577 | publication date | 2015-07-08 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys | |
| P478 | volume | 89 |
| Q37252913 | Characterization of Simian Immunodeficiency Virus Variants Anatomically Compartmentalized in Plasma and Milk in Chronically Infected African Green Monkeys |
| Q37072545 | Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus |
| Q38744569 | Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission |
| Q55411829 | Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys. |
Search more.